Last $125.07 USD
Change Today -0.44 / -0.35%
Volume 1.1M
TMO On Other Exchanges
Symbol
Exchange
New York
Stuttgart
Mexico
As of 8:04 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

thermo fisher scientific inc (TMO) Snapshot

Open
$124.30
Previous Close
$125.51
Day High
$125.34
Day Low
$124.30
52 Week High
03/6/14 - $127.63
52 Week Low
08/28/13 - $88.13
Market Cap
49.9B
Average Volume 10 Days
2.6M
EPS TTM
$3.74
Shares Outstanding
398.9M
EX-Date
09/11/14
P/E TM
33.4x
Dividend
$0.60
Dividend Yield
0.48%
Current Stock Chart for THERMO FISHER SCIENTIFIC INC (TMO)

thermo fisher scientific inc (TMO) Details

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics in the United States and internationally. It operates in three segments: Analytical Technologies; Specialty Diagnostics; and Laboratory Products and Services. The Analytical Technologies segment offers instruments, reagents, consumables, software, and services for a range of applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as the clinical laboratory. The Specialty Diagnostics segment provides various diagnostic test kits, reagents, culture media, instruments, and associated products that are used by customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. This segment offers blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; human leukocyte antigen typing and testing for the organ transplant; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; and products for cancer diagnosis and medical research in histology, cytology, and hematology applications. The Laboratory Products and Services segment offers laboratory equipment, including sample preparation and preservation equipment, cold storage equipment, centrifugation products, biological safety cabinets, temperature control products, water analysis instruments, and other laboratory equipment, as well as laboratory consumables, research and safety market solutions, and biopharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

50,000 Employees
Last Reported Date: 07/23/14
Founded in 1956

thermo fisher scientific inc (TMO) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: $1.1M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $653.7K
Executive Vice President and President of Lab...
Total Annual Compensation: $697.9K
Senior Vice President and President of Analyt...
Total Annual Compensation: $514.1K
Chief Commercial Officer and Senior Vice Pres...
Total Annual Compensation: $622.6K
Compensation as of Fiscal Year 2013.

thermo fisher scientific inc (TMO) Key Developments

Thermo Fisher Scientific, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 28, 2014; Raises Earnings Guidance for the Full Year 2014; Provides Earnings Outlook for the Third Quarter of 2014

Thermo Fisher Scientific, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 28, 2014. For the quarter, the company reported revenues of $4,321.9 million against $3,240.1 million a year ago. Operating income was $348.1 million against $375.4 million a year ago. Income before income taxes was $236.5 million against $280.0 million a year ago. Income from continuing operations was $278.5 million or $0.69 per diluted share against $277.6 million or $0.76 per diluted share a year ago. Net income was $278.5 million or $0.69 per diluted share against $277.4 million or $0.76 per diluted share a year ago. Adjusted operating income was $923.6 million against $623.8 million a year ago. Adjusted net income was $695.1 million or $1.72 per diluted share against $478.7 million or $1.32 per diluted share a year ago. GAAP net cash provided by operating activities was $888.7 million against $478.4 million a year ago. Purchases of property, plant and equipment were $75.5 million against $65.6 million a year ago. Free cash flow was $823.4 million against $414.3 million a year ago. For the six months period, the company reported revenues of $8,225.4 million against $6,431.6 million a year ago. Operating income was $1,223.6 million against $762.5 million a year ago. Income before income taxes was $1,010.9 million against $622.9 million a year ago. Income from continuing operations was $821.6 million or $2.05 per diluted share against $618.4 million or $1.71 per diluted share a year ago. Net income was $821.6 million or $2.05 per diluted share against $613.6 million or $1.69 per diluted share a year ago. Adjusted operating income was $1,754.1 million against $1,238.9 million a year ago. Adjusted net income was $1,305.9 million or $3.26 per diluted share against $974.4 million or $2.69 per diluted share a year ago. GAAP net cash provided by operating activities was $989.9 million against $776.7 million a year ago. Purchases of property, plant and equipment were $180.2 million against $131.6 million a year ago. Free cash flow was $824.3 million against $650.4 million a year ago. The company provided earnings outlook for the third quarter of 2014. In terms of revenue, the company expects to represent about 25% of company's full year revenue guidance midpoint. Adjusted EPS is expected to be in the range of $1.65 to $1.70. The company has revised earnings guidance for the full year 2014. The company now expects revenues for 2014 to be in the range of $16.86 billion to $16.98 billion for 29% to 30% revenue growth year-over-year as previously announced. The company is raising its adjusted EPS guidance to a new range of $6.85 to $6.97, which now results in 26% to 29% growth over 2013. The company is expecting net interest expense to be in the range of $425 million to $435 million, down slightly from previous guidance as a result of paying down debt more quickly. The company is expecting adjusted income tax rate to be in the regional 14.5% to 15.5%, consistent with previous guidance.

Thermo Fisher Scientific Inc. Unveils Thermo Scientific Vanquish UHPLC

Thermo Fisher Scientific Inc. has unveiled Thermo Scientific Vanquish UHPLC, a new liquid chromatography system designed to provide new levels of performance, productivity and usability when used as a standalone system or with the latest mass spectrometers. The new Thermo Scientific Vanquish UHPLC looks different from standard UHPLC systems, and there are benefits to its clean design. The monolithic case contains an instrument that combines the ruggedness of an integrated system with the flexibility and serviceability of a modular system. Vanquish stands about 25% lower than comparable modular stacks for safety and convenience in the laboratory. Central to the Vanquish concept is the new family of Thermo Scientific Accucore Vanquish UHPLC columns, specially designed to optimize performance. The new columns feature 1.5 µm solid core particles utilizing Core Enhanced Technology to take full advantage of the Vanquish system's 1500 bar (22,000 psi) maximum pump pressure and flow rate up to 5mL/min for ultra-short diffusion path lengths and highly efficient separations. Other features add to the system's performance, throughput and usability, including: SmartFlow pumping technology designed for highly reproducible retention times and low baseline noise to enhance detection sensitivity; temperature control capabilities, including direct heating and forced air temperature control modules in the column compartment, further enhancing separation efficiency and selectivity, as well as retention time reproducibility; and an insulated autosampler compartment with new air-to-air cooling, which protects vials from water condensation, even in hot and humid environments. Additional features include: Gold-standard Thermo Scientific Dionex Chromeleon Chromatography Data System, familiar in laboratories around the world, which can calibrate the system automatically and while unattended. eWorkflow and Intelligent Run Control automation are designed to enhance data quality and instrument efficiency. Instant data reprocessing paired with Cobra Peak Detection and Smart Link can speed data review significantly compared to manual procedures. Chromeleon software supports chromatography and mass spectrometry functions simultaneously and Optional handheld tablet lets users conveniently monitor system status, check runs and make changes. For high sample throughput applications, the optional Thermo Scientific Vanquish Charger is a fully integrated robotic module that provides unattended, environmentally controlled sample management and loading into the Vanquish UHPLC system. It accommodates up to nine sample racks, deep well plates or 20 shallow well plates. This includes a bar code reader with empty shelf detection and rack/well plate verification. Users can add samples at any time, even while the instrument is operating, to enable maximum throughput and usability. Hard carbon-coated ceramic injection valve and pump pistons are designed to deliver consistent, reproducible performance for 200,000 injections, further enhancing uptime by minimizing maintenance. The Vanquish's Diode Array Detector is designed to generate high-confidence data over a wide linear range with high signal-to-noise performance, beyond the capabilities of variable wavelength detectors. Low-dispersion 10 mm and 60 mm flow cells provide high sensitivity levels and wide linearity for demanding applications. Fused-silica LightPipe flow cells are designed to exploit low baseline drift for reproducible quantitation. Customers can acquire up to 10 signal channels simultaneously, and a spectrum 3D field at 200 Hz. Sensitivity, linearity, and spectral resolution can be tailored to suit the application using four programmable optical slit widths from 1 nm to 8 nm.

Thermo Fisher Scientific, Inc. Declares Quarterly Cash Dividend, Payable on October 15, 2014

Thermo Fisher Scientific Inc. announced that its board of directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on October 15, 2014, to shareholders of record as of September 15, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMO:US $125.07 USD -0.44

TMO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $43.04 USD +0.15
Becton Dickinson and Co $118.37 USD -0.12
Corning Inc $22.02 USD -0.07
Danaher Corp $75.69 USD -0.28
Merck KGaA €64.23 EUR -0.99
View Industry Companies
 

Industry Analysis

TMO

Industry Average

Valuation TMO Industry Range
Price/Earnings 32.6x
Price/Sales 3.4x
Price/Book 2.4x
Price/Cash Flow 29.0x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERMO FISHER SCIENTIFIC INC, please visit www.thermofisher.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.